COVID-19

Keys to accelerating your COVID-19 drug campaign

As SARS-CoV-2 moves fast through our global population, the pharmaceutical industry faces tremendous pressure to move even faster.

Read More
ATMP Facility Design

5 considerations for a commercial scale ATMP facility

Commercial scale is not far-off for advanced therapy medicinal product (ATMP) facilities.

Read More
ATMP

How to deliver multi-product ATMP facilities for future flexibility

Manufacturers must produce a variety of ATMPs quickly and efficiently. Enter the multi-product ATMP facility.

Read More
fast-track design and construction

Fast-tracking design and construction to save more lives

Ensuring that patients receive novel medicines is a key driver for working to reduce the time it takes to design and build a new biopharmaceutical facility.

Read More
Cell and gene therapy

Cell and gene therapy facility design molded by commercial biopharma experience

Interview with Niranjan Kulkarni, Senior Director, Allan Bream, Process Specialist, and Grace Linton, Process Architect at CRB that originally appeared in Cell and Gene Therapy Insights, on how commercial biopharma experience is shaping cell and gene therapy facility design.

Read More
ATMP

Choose your playing field: ATMP site selection

So you want to build a new facility for advanced therapy manufacture? Before you start building, there is one essential element that you need to get right: site selection.

Read More
BIM 3D

Using digital tools to optimize facility design

Building information modeling software improves efficiency. Technology, like BIM, is changing more than just healthcare’s latest therapeutic modalities and pharmaceutical advances. It’s also disrupting the design and implementation of the facilities that create them.

Read More
Lean delivery

Reducing waste with lean delivery in facility design and construction

Applying a lean delivery approach to the design and construction of new facilities can reduce waste, lower costs and improve speed to market.

Read More
Membrane-Based RO Systems for WFI

Membrane-based reverse osmosis systems for WFI production

Water for injection (WFI) is used in the pharmaceutical industry to formulate parenteral drugs and for cleaning and other manufacturing operations. Reverse osmosis followed by a polishing step can be a more efficient and cost-effective solution for WFI production.

Read More
ATMP

NextGen Now: Delivering tomorrow’s facilities today

If cell and gene therapy products are to successfully reach patients and deliver transformative cures, then the industry will need more facilities capable of manufacturing them.

Read More

Biotechnology Newsletter

Be the first to receive The Next Biotechnology Insights.
  • This field is for validation purposes and should be left unchanged.